ALUROTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as ALURW
ALLURION TECHNOLOGIES, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 15, 2026
$0.47+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.34M
- P/E (TTM)
- –
- Dividend yield
- –
ALLURION TECHNOLOGIES, INC. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | % of revenue | YoY |
|---|---|---|---|---|---|---|
| All Other Countries | $11.24M | $25.42M | $35.08M | $42.24M | 73.8% | -55.8% |
| Spain | $2.15M | $4.01M | $4.62M | $6.85M | 14.1% | -46.3% |
| Italy | $1.84M | $2.69M | – | – | 12.1% | -31.5% |
| United States | $0 | $0 | $0 | – | 0.0% | – |
| France | – | $2.49M | $5.57M | $6.03M | – | – |
| Chile | – | – | $2.71M | $5.01M | – | – |
| TRY | – | $1.57M | $5.49M | $4.08M | – | – |
From the segment and revenue-disaggregation notes of Allurion Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.